Ace:
News
Day care and treatment
The United States approves the use of Aducanumab: a treatment for Alzheimer's disease
11/06/2021
Ace Alzheimer Center Barcelona participated in Biogen's clinical trial for the drug Aducanumab. During the clinical trial, we were the sixth center that was able to include the most people in the study worldwide and the first in Europe.
BLOG | Stages of Alzheimer’s
03/11/2020News
Dr. Mercè Boada explains the three stages of Alzheimer's, with specific examples of the behavior of the person with dementia depending on the stage in which they are.
We expand cognitive stimulation exercises thanks to Kern Pharma
28/10/2020SCR
Kern Pharma provides people with mild and moderate cognitive impairment with various exercises available on our website in addition to those that Fundación ACE made available to the public during the state of alarm.
Carla Abdelnour, speaker at the XVIII annual meeting of the Madrid Neurology Association
22/10/2020Training
Dr. Carla Abdelnour, neurologist and member of the Fundació ACE clinical trials team, participates in the XVIII annual meeting of the AMN (Madrid Neurology Association) with a presentation entitled "Clinical aspects of dementia with Lewy bodies"
Fundació ACE’s career has been institutionally recognized by Les Corts district
21/10/2020Awareness
The district of Les Corts recognized the trajectory of Fundación ACE during the Plenary Council held on October 7, 2020
We are waiting for you on the first Alzheimer's Night online
20/10/2020Awareness
The fifth edition of La Noche del Alzheimer will be held on December 2, 2020 at 7:00 p.m. and will be the first online edition. Join us and help us take care of people with Alzheimer's.